Loading...
Pharvaris N.V.
PHVS•NASDAQ
Healthcare
Biotechnology
$20.62
$0.57(2.84%)
Pharvaris N.V. (PHVS) Financial Performance & Income Statement Overview
Review Pharvaris N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
0.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
-29.10%
↓ 29.10%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-54.35%
↓ 54.35%
ROIC
-13.32%
↓ 13.32%
Pharvaris N.V. (PHVS) Income Statement & Financial Overview
Review Pharvaris N.V.'s (PHVS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $69024.00 | $66745.00 |
| Gross Profit | $0.00 | $0.00 | -$69024.00 | -$66745.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $31.20M | $25.78M | $23.07M | $18.51M |
| SG&A Expenses | $13.89M | $12.12M | $11.31M | $9.80M |
| Operating Expenses | $45.09M | $37.90M | $34.38M | $28.31M |
| Total Costs & Expenses | $45.09M | $37.90M | $34.38M | $28.31M |
| Interest Income | $0.00 | $1.98M | $0.00 | $0.00 |
| Interest Expense | $0.00 | $9135.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $90958.00 | $43572.00 | $68677.00 | $66745.00 |
| EBITDA | -$45.001M | -$37.86M | -$34.31M | -$28.25M |
| EBITDA Ratio | ||||
| Operating Income | $0.00 | -$37.90M | -$34.38M | -$28.31M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$33.52M | -$3.58M | $4.72M | $578220.00 |
| Income Before Tax | -$33.52M | -$41.48M | -$29.66M | -$27.73M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $1.24M | $230091.00 | $70623.00 | $285117.00 |
| Net Income | -$34.76M | -$41.71M | -$29.73M | -$28.02M |
| Net Income Ratio | ||||
| EPS | -$0.64 | -$0.77 | -$0.55 | -$0.52 |
| Diluted EPS | -$0.64 | -$0.77 | -$0.55 | -$0.52 |
| Weighted Avg Shares Outstanding | $54.07M | $54.07M | $53.94M | $53.82M |
| Weighted Avg Shares Outstanding (Diluted) | $54.07M | $54.07M | $53.94M | $53.82M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan